MCM
M28 Capital Management Portfolio holdings
AUM
$58.6M
This Quarter Return
+6.86%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
(+12%)
Cap. Flow
+$1.86M
Cap. Flow
% of AUM
1.38%
Top 10 Holdings %
Top 10 Hldgs %
98.58%
Holding
11
New
1
Increased
–
Reduced
6
Closed
–
Top Buys
| 1 |
Fractyl Health
GUTS
|
$13.7M |
Top Sells
| 1 |
Rocket Pharmaceuticals
RCKT
|
$3.71M |
| 2 |
Wave Life Sciences
WVE
|
$2.3M |
| 3 |
ProQR Therapeutics
PRQR
|
$2.04M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$1.59M |
| 5 |
SLN
Silence Therapeutics
SLN
|
$1.39M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Wave Life Sciences
WVE
$1.53B
| $43.2M | 31.91% |
7,000,000
-373,413
| -5% | -$2.3M |
|
2
Invivyd
IVVD
$216M
| $41.1M | 30.34% |
9,248,250
| – | – |
|
|
3
Fractyl Health
GUTS
$69.2M
| $13.7M | 10.15% |
+1,856,117
| New | +$13.7M |
|
|
4
Rocket Pharmaceuticals
RCKT
$350M
| $10.4M | 7.68% |
385,680
-137,600
| -26% | -$3.71M |
|
|
SLN
5
Silence Therapeutics
SLN
$225M
| $6.47M | 4.78% |
299,400
-64,400
| -18% | -$1.39M |
|
|
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
| $5.43M | 4.02% |
110,400
-32,400
| -23% | -$1.59M |
|
7
Curis
CRIS
$20.5M
| $4.59M | 3.39% |
421,951
| – | – |
|
8
BridgeBio Pharma
BBIO
$9.56B
| $3.75M | 2.77% |
121,200
| – | – |
|
9
TG Therapeutics
TGTX
$4.72B
| $2.46M | 1.82% |
161,600
-55,000
| -25% | -$837K |
|
|
10
ProQR Therapeutics
PRQR
$241M
| $2.33M | 1.73% |
1,019,498
-891,102
| -47% | -$2.04M |
|
11
Arrowhead Research
ARWR
$3.55B
| $1.93M | 1.42% |
67,400
| – | – |
|